Treatment modalities of hepatocellular carcinoma;Les traitements du carcinome hépatocellulaire

Presse Medicale

Volumn 30, Issue 23, 2001, Pages 1170-1177

  Veilhan, L A ^a   Adam, R ^a  

^a HÔPITAL PAUL BROUSSE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IODINATED POPPYSEED OIL;

ARTIFICIAL EMBOLISM; CANCER SURVIVAL; CRYOTHERAPY; HUMAN; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; REVIEW; SURGICAL TECHNIQUE; SURVIVAL RATE; TREATMENT PLANNING; ALCOHOL LIVER CIRRHOSIS; ARTICLE; DIAGNOSTIC IMAGING; LIVER; LIVER RESECTION; LIVER TUMOR; PATHOLOGY; PROGNOSIS;

CARCINOMA, HEPATOCELLULAR; DIAGNOSTIC IMAGING; HEPATECTOMY; HUMANS; LIVER; LIVER CIRRHOSIS, ALCOHOLIC; LIVER NEOPLASMS; LIVER TRANSPLANTATION; PROGNOSIS;

EID: 0035822517     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (65)

1. Epidemiology of hepatocellular carcinoma
2. Prospective study of screening for hepatocellular carcinoma in Caucasian patients with cirrhosis
3. Screening for hepatocellular carcinoma in patients with Child's A cirrhosis: An 8-year prospective study by ultrasound and alphafetoprotein
4. Hepatocellular carcinoma in italian patients with cirrhosis
5. Natural history of hepatocellular carcinoma and prognosis in relation to treatment Study of 850 patients
6. Natural history of untreated nonsurgical hepatocellular carcinoma: Rationale for the design and evaluation of therapeutic trials
7. The natural history of hepatocellular carcinoma. A study of 100 untreated cases
8. Natural history of hepatocellular carcinoma in Spain. Five year's experience in 249 cases
9. Ultrasonically guided subsegmentectomy
10. Transection of the oesophagus for bleeding oesophageal varices
11. Surgical treatment of hepatocellular carcinoma on cirrhosis: A Western experience
12. Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis
13. Recurrence of hepatocellular carcinoma after surgery
14. Repeat hepatectomy for recurrent hepatocellular carcinoma
15. Aggressive management of recurrence following surgical resection of hepatocellular carcinoma
16. Resection of hepatocellular carcinomas. Results in 72 European patients with cirrhosis
17. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: Resection versus transplantation
18. Liver resection for hepatocellular carcinoma. Results of 229 consecutive patients during 11 years
19. Long-term results after resection of hepatocellular carcinoma: Experience of 480 cases
20. Influence of preoperative transarterial Lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis
21. Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: A prospective randomised trial
22. Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: A randomised trial
23. Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma
24. Percutaneous portal vein embolization increases the feasibility and safety of major resection for hepatocellular carcinoma in injured liver
25. Primary liver resection and salvage transplantation or primary transplantation in patients with single, small hepatocellular carcinoma and preserved liver function: An outcome-oriented decision analysis
26. Postoperative hepatitis status as a significant risk factor for recurrence in cirrhotic patients with small hepatocellular carcinoma
27. Patterns of recurrence after initial treatment in patients with small hepatocellular carcinoma
28. Role of liver transplantation in cancer therapy
29. Liver transplantation for malignant disease. Results in 93 consecutive patients
30. Is liver transplantation justified for the treatment of hepatic malignancies?
31. Results of orthotopic liver transplantation for liver cirrhosis in the presence of incidental and/or undetected hepatocellular carcinoma and tumor characteristics
32. Undetected hepatocellular carcinoma: Clinical features and outcome after liver transplantation
33. Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients
34. Liver transplantation of small hepatocellular carcinomas in patients with cirrhosis
35. Liver transplantation for small hepatocellular carcinoma: The tumor-node-metastasis classification does not have prognostic power
36. Recurrence-free survival after liver transplantation
37. Survival after liver transplantation in cirrhotic patients with and without hepatocellular carcinoma: A comparative study
38. Indications et résultats de la transplantation hépatique dans le traitement des carcinomes hépatocellulaires sur cirrhose
39. Primary treatment of hepatocellular carcinoma by arterial chemoembolization
40. Chemoembolization of hepatocellular carcinoma in patients who undergo liver transplantation
41. Arterial chemoembolization before liver transplantation in patients with hepatocellular carcinoma: Marked tumor necrosis, but no survival benefit?
42. Preoperative hepatic artery chemoembolization followed by orthotopic liver transplantation for hepatocellular carcinoma
43. Small hepatocellular carcinoma: Treatment with radiofrequency ablation versus ethanol injection
44. Hepatocellular carcinoma and cirrhosis in 746 patients: Long-term results of percutaneous ethanol injection
45. Long-term results of percutaneous ethanol injection therapy for hepatocellular carcinoma in cirrhosis: A European experience
46. Place of cryosurgery in the treatment of malignant liver tumors
47. Cryotherapy for primary liver cancer
48. Radio-frequency ablation of hepatocellular cancer in 110 patients with cirrhosis
49. A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma
50. Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: A multicenter randomized trial
51. Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: Results of randomized, controlled trial in a single institution
52. Chemoembolization improves survival in patients with unresectable hepatocellular carcinoma
53. Hepatic artery injection of 1-131-labeled lipiodol. Part I. Biodistribution study results in patients with hepatocellular carcinoma and liver metastases
54. Prospective randomized trial of chemoembolization versus intra-arterial injection of 311-labeled-iodized oil in the treatment of hepatocellular carcinoma
55. Randomized controlled trial for hepatocellular carcinoma with portal vein thrombosis: Intra-arterial iodine-131-iodized oil versus medical support
56. Unresectable hepatocellular carcinoma: A prospective controlled trial with tamoxifen
57. Controlled trial of tamoxifen in patients with advanced hepatocellular carcinoma
58. Treatment of hepatocellular carcinoma with combined suppression and inhibition of sex hormones: A randomised, controlled trial
59. Treatment of hepatocellular carcinoma with tamoxifen: A double-blind placebo-controlled trial in 120 patients
60. Tamoxifen in treatment of hepatocellular carcinoma: A randomised controlled trial
61. Treatment of hepatocellular carcinoma with octreotide: A randomised controlled study
62. Randomized controlled trial of interferon treatment for advanced hepatocellular carcinoma
63. Hepatocellular carcinoma occurring in nonfibrotic liver: Epidemiologic and histopathologic analysis of 80 french cases
64. Surgical treatment of hepatocellular carcinomas in non cirrhotic liver: Experience with 68 liver resections